Oral explanation to be held on Wednesday 25 March 2015 at 11.00, page-32

I think the blame lies mainly with the regulatory bodies - BSI who were supposed to be looking after our interests and, when the CE Mark was imminent, had second thoughts about the classification of VitroGro and referred it to the MHRA who passed it on to the EMA who ultimately had to be taken to court before they would accept the product as a device. Not much the CEO or board could do once the application went into the regulatory system .... was it 3 years ago!?!